Assistance Publique - Hôpitaux de Paris: Glioblastoma trials
The registry lists 10 Glioblastoma studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 1 3Phase 2 7Phase 3 2No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Impact of Androgen Signaling on the Composition of the Immune Microenvironment in GlioblastomasNot yet recruitingNCT07472387Not applicable
- New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a StudyRecruitingNCT06622434Phase 1/2
- Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients.Status unknownNCT04614493Phase 2
- Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma PatientsStatus unknownNCT03294486Phase 1/2
- Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional StatusCompletedNCT02898012Phase 2
- Safety of BBB Opening With the SonoCloudCompletedNCT02253212Phase 1/2
- Angiotensin II Receptor Blockers, Steroids and Radiotherapy in GlioblastomaCompletedNCT01805453Phase 3
- Temozolomide in Elderly Patients With KPS < 70CompletedNCT01242566Phase 2
- Radiotherapy for Malignant Astrocytomas in the ElderlyCompletedNCT00430911Phase 3
- Randomized Phase 2 With CpG-ODN in Malignant GlioblastomaCompletedNCT00190424Phase 2